Predictive Financial Statements From 2010 to 2025
| POAIDelisted Stock | USD 5.95 0.00 0.00% |
Check Predictive Oncology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Predictive Oncology's main balance sheet or income statement drivers, such as , as well as many indicators such as . Predictive financial statements analysis is a perfect complement when working with Predictive Oncology Valuation or Volatility modules.
Predictive |
Predictive Oncology Company Return On Equity Analysis
Predictive Oncology's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Predictive Oncology Return On Equity | -7.46 |
Most of Predictive Oncology's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Predictive Oncology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Predictive Oncology has a Return On Equity of -7.4603. This is 68.88% lower than that of the Health Care Equipment & Supplies sector and 24.75% higher than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Predictive Oncology Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Predictive Oncology's current stock value. Our valuation model uses many indicators to compare Predictive Oncology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Predictive Oncology competition to find correlations between indicators driving Predictive Oncology's intrinsic value. More Info.Predictive Oncology is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Predictive Oncology's earnings, one of the primary drivers of an investment's value.About Predictive Oncology Financial Statements
Investors use fundamental indicators, such as Predictive Oncology's revenue or net income, to determine how well the company is positioned to perform in the future. Although Predictive Oncology's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence primarily in the United States. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota. Predictive Oncology operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Predictive Stock
If you are still planning to invest in Predictive Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Predictive Oncology's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |